COVID-19 mRNA Vaccine BNT162b2 Pfizer/BioNTech Vaccine National Protocol

This protocol is for the supply and administration of COVID-19 mRNA Vaccine BNT162b2 Pfizer/BioNTech to individuals in accordance with the national COVID-19 vaccination programme.


Supporting documents

Back to top